Your browser doesn't support javascript.
loading
The renal safety and efficacy of combined gemcitabine plus cisplatin and gemcitabine plus carboplatin chemotherapy in Chinese patients with a solitary kidney after nephroureterectomy.
Sun, Peng; Xue, Cong; Li, Li-Ren; Shao, Cui; An, Xin; Thomas, Ried; Yang, Wei; Deng, Ying-Fei; Jiang, Wen-Qi; Shi, Yan-Xia.
Afiliação
  • Sun P; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Xue C; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Li LR; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Shao C; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • An X; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Thomas R; Department of Colorectal Surgery, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Yang W; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Deng YF; Department of Medical Oncology, Sun Yat-Sen University Cancer Center, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
  • Jiang WQ; Guangzhou University of Chinese Medicine, 12 Airport Road, Guangzhou, 510403, Guangdong, People's Republic of China.
  • Shi YX; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, 651 Dong Feng Road East, Guangzhou, 510060, Guangdong, People's Republic of China.
Cancer Chemother Pharmacol ; 80(1): 37-44, 2017 Jul.
Article em En | MEDLINE | ID: mdl-28534209
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Carcinoma de Células de Transição / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais / Nefrectomia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ureterais / Carcinoma de Células de Transição / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais / Nefrectomia Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Chemother Pharmacol Ano de publicação: 2017 Tipo de documento: Article